Bionor (Norway)

Bionor (Norway)

Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Bionor (Norway), Norway, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

59%


Total
Publications

66


Total Open
Publications

39


Total
Citations

1.3K


Open Access
Percentage

59%


Total
Publications

66


Total Open
Publications

39


Total
Citations

1.3K

Wikipedia

Website

download

Breakdown

31% 25% 2% 42%

Publisher Open

31%

Both

25%

Other Platform Open

2%

Closed

42%

Percentage of Open Access over time

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678910Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

12

Hybrid 56%

20

No Guarantees 11%

4

Other Platform Open

Institution 78%

14

Other Internet 39%

7

Domain 22%

4

Public 22%

4

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

DOI
Other Internet
5
University of Skopje - Macedonian Journal of Medical Sciences
Institution
4
PubMed Central
Domain
4
Unknown Repository
Other Internet
3
Université de Lausanne - SERVAL
Institution
3
Figshare
Public
3
embrapa.br OAI-PMH Repository
Institution
3
University of Oslo - Duo Research Archive
Institution
2
usp.br OAI-PMH Repository
Institution
1
UNSW Sydney - UNSWorks
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share